Source: PMLiVE

Exscientia: AI specialist Exscientia buys Kinetic Discovery

The biophysics tech will radically improve the drug discovery paradigm, says Exscientia

Read full article »
Exscientia's Competitors | Exscientia's News | Exscientia's Financials
Stay up-to-date with the latest news on Exscientia
Est. Annual Revenue
$5.0-25M
Est. Employees
100-250
Andrew Hopkins's photo - Founder & CEO of Exscientia

Founder & CEO

Andrew Hopkins

CEO Approval Rating

81/100

Read more
Stay up-to-date with the latest news on Exscientia